XYL
33
-2
GT
37
-2
TMO
64
2
BRK.B
42
2
SJM
11
-3
USB
66
-2
EA
47
3
VMC
57
4
CPB
35
-4
DOW
39
-3
AA
80
-3
GRMN
39
-6
A
44
-7
ORLY
43
2
PPL
59
2
IRM
46
2
HIG
68
-2
ADP
53
-2
CMA
65
-6
TAP
35
-2
XYL
33
-2
GT
37
-2
TMO
64
2
BRK.B
42
2
SJM
11
-3
USB
66
-2
EA
47
3
VMC
57
4
CPB
35
-4
DOW
39
-3
AA
80
-3
GRMN
39
-6
A
44
-7
ORLY
43
2
PPL
59
2
IRM
46
2
HIG
68
-2
ADP
53
-2
CMA
65
-6
TAP
35
-2
Financhill
Back

Goldman Sachs ActiveBeta US Large Cap Equity ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
61

GSLC
Goldman Sachs ActiveBeta US Large Cap Equity ETF

Last Price:
$133.70
Seasonality Move:
3.87%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.39
Seasonality Move:
-34.19%
Buy
61
Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) is a Buy

Is Goldman Sachs ActiveBeta US Large Cap Equity ETF a Buy, Sell or Hold?

  • The current Goldman Sachs ActiveBeta US Large Cap Equity ETF [GSLC] share price is $133.47. The Score for GSLC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • GSLC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GSLC Stock Price Chart

What is Goldman Sachs ActiveBeta US Large Cap Equity ETF's stock price today?

  • The Goldman Sachs ActiveBeta US Large Cap Equity ETF share price today is $133.47
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GSLC is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GSLC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.54 Buy
Relative Strength Index (14 RSI): 58.82 Buy
Chaikin Money Flow: 114149 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (129.2 - 133.24) Buy
Bollinger Bands (100): (126.61 - 131.97) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

GSLC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 132.29 Buy
20-day SMA: 132.11 Buy
50-day SMA: 131.02 Buy
200-day SMA: 121.88 Buy
8-day EMA: 132.33 Buy
20-day EMA: 131.9 Buy
50-day EMA: 128.87 Buy
200-day EMA: 83.01 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Goldman Sachs ActiveBeta US Large Cap Equity ETF Earnings Growth & GSLC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Goldman Sachs ActiveBeta US Large Cap Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):